SlideShare una empresa de Scribd logo
1 de 27
PHARMACOECONOMICS ,[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Preview
PHARMACOECONOMICS RESEARCH ,[object Object],[object Object],[object Object],[object Object]
VALUE Health Outcome Cost
USE OF PHARMACOECONOMIC RESEARCH ,[object Object],[object Object],[object Object],[object Object],[object Object]
NEEDS TO MONITOR VALUE OF PHARMACEUTICALS ,[object Object],[object Object],[object Object],[object Object]
TYPES OF PHARMACOECONOMIC EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object]
COMPARING PHARMACOECONOMIC METHODOLOGIES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
STEPS FOR CONDUCTING A PHARMACOECONOMIC EVALUATION ,[object Object],[object Object],[object Object],[object Object]
DEFINE THE PROBLEM AND STATE THE OBJECTIVE ,[object Object],[object Object]
PERSPECTIVE ,[object Object],[object Object],[object Object],[object Object]
PERSPECTIVE ,[object Object]
IDENTIFYING ALTERNATIVE INTERVENTIONS ,[object Object]
IDENTIFYING ALTERNATIVE INTERVENTIONS ,[object Object]
IDENTIFY AND MEASURE OUTCOMES OF EACH ALTERNATIVE INTERVENTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
OUTCOMES ,[object Object],[object Object],[object Object]
IDENTIFYING,MEASUREMENT AND VALUATION OF COSTS ,[object Object],[object Object]
IDENTIFYING RELEVANT COSTS ,[object Object],[object Object]
COSTS ,[object Object],[object Object],[object Object]
Costs can be described in many ways ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MEASURING COSTS ,[object Object],[object Object]
VALUING COSTS ,[object Object]
SENSITIVITY ANALYSIS ,[object Object],[object Object]
DISCOUNTING ,[object Object],[object Object]
JOURNALS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
REFERENCES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ASSIGNMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
Tulasi Raman
 
Vaccine Safety Monitoring: Pharmacovigilance Strategies
Vaccine Safety Monitoring: Pharmacovigilance StrategiesVaccine Safety Monitoring: Pharmacovigilance Strategies
Vaccine Safety Monitoring: Pharmacovigilance Strategies
ClinosolIndia
 
Cost minimisation analysis in health economics
Cost minimisation analysis in health economicsCost minimisation analysis in health economics
Cost minimisation analysis in health economics
a01071979
 

La actualidad más candente (20)

Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics by harsh
Pharmacoeconomics by harshPharmacoeconomics by harsh
Pharmacoeconomics by harsh
 
Seminar pharmacoeconomics
Seminar pharmacoeconomicsSeminar pharmacoeconomics
Seminar pharmacoeconomics
 
Pharmacoeconomics methods & its issues
Pharmacoeconomics methods & its issuesPharmacoeconomics methods & its issues
Pharmacoeconomics methods & its issues
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018
 
breast cancer pharmacotherapy
breast cancer pharmacotherapybreast cancer pharmacotherapy
breast cancer pharmacotherapy
 
Vaccine Safety Monitoring: Pharmacovigilance Strategies
Vaccine Safety Monitoring: Pharmacovigilance StrategiesVaccine Safety Monitoring: Pharmacovigilance Strategies
Vaccine Safety Monitoring: Pharmacovigilance Strategies
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicine
 
ADR AND ITS MONITORING
ADR  AND  ITS MONITORING ADR  AND  ITS MONITORING
ADR AND ITS MONITORING
 
basic information resource.pptx
basic information resource.pptxbasic information resource.pptx
basic information resource.pptx
 
Pharmacoeconomics pptx
Pharmacoeconomics pptxPharmacoeconomics pptx
Pharmacoeconomics pptx
 
INTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptxINTRODUCTION TO PHARMACOECONOMICS.pptx
INTRODUCTION TO PHARMACOECONOMICS.pptx
 
Cost minimisation analysis in health economics
Cost minimisation analysis in health economicsCost minimisation analysis in health economics
Cost minimisation analysis in health economics
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
 
Pharmacogenetics
PharmacogeneticsPharmacogenetics
Pharmacogenetics
 
Pharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisPharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysis
 

Destacado

Pharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSAPharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSA
Stevce Acevski
 
Josh feldstein hopr (presentation)
Josh feldstein hopr (presentation)Josh feldstein hopr (presentation)
Josh feldstein hopr (presentation)
jonblanck
 
The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...
Sax Institute
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Dr.Sohel Memon
 
Neoplasia Etiology and pathogenesis of cancer
Neoplasia Etiology and pathogenesis of cancerNeoplasia Etiology and pathogenesis of cancer
Neoplasia Etiology and pathogenesis of cancer
Subramani Parasuraman
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
Govind Girase
 

Destacado (20)

Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSAPharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSA
 
Pharmacoeconomics seminar
Pharmacoeconomics seminarPharmacoeconomics seminar
Pharmacoeconomics seminar
 
Intro to pharmacoeconomics
Intro to pharmacoeconomicsIntro to pharmacoeconomics
Intro to pharmacoeconomics
 
Evaluating Health Technology Assessment Reports and New Assessment Techniques...
Evaluating Health Technology Assessment Reports and New Assessment Techniques...Evaluating Health Technology Assessment Reports and New Assessment Techniques...
Evaluating Health Technology Assessment Reports and New Assessment Techniques...
 
Hol webinar summary
Hol webinar summaryHol webinar summary
Hol webinar summary
 
Pharmacoeconomic moh program 1
Pharmacoeconomic moh program 1Pharmacoeconomic moh program 1
Pharmacoeconomic moh program 1
 
Pharmacoeconomic Assessment through Market Approval and Beyond
Pharmacoeconomic Assessment through Market Approval and BeyondPharmacoeconomic Assessment through Market Approval and Beyond
Pharmacoeconomic Assessment through Market Approval and Beyond
 
Basics of pharmacoeconomics_and_outcomes_research (2)
Basics of pharmacoeconomics_and_outcomes_research (2)Basics of pharmacoeconomics_and_outcomes_research (2)
Basics of pharmacoeconomics_and_outcomes_research (2)
 
Josh feldstein hopr (presentation)
Josh feldstein hopr (presentation)Josh feldstein hopr (presentation)
Josh feldstein hopr (presentation)
 
The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...
 
HTA training - Dr Roisin Adams - March 27th 2016
HTA training - Dr Roisin Adams - March 27th 2016HTA training - Dr Roisin Adams - March 27th 2016
HTA training - Dr Roisin Adams - March 27th 2016
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
 
Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig UniversityHistology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
Histology Practical Slides For CLinicaL Pharmacy ☮ Zagazig University
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
Neoplasia Etiology and pathogenesis of cancer
Neoplasia Etiology and pathogenesis of cancerNeoplasia Etiology and pathogenesis of cancer
Neoplasia Etiology and pathogenesis of cancer
 
5 easy ways to create fabulous slides
5 easy ways to create fabulous slides5 easy ways to create fabulous slides
5 easy ways to create fabulous slides
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 

Similar a Pharmacoeconomics1

Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1
jinender16
 
Accounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docxAccounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docx
nettletondevon
 

Similar a Pharmacoeconomics1 (20)

Outcomes, health economics and pharmacoeconomics
Outcomes, health economics and  pharmacoeconomicsOutcomes, health economics and  pharmacoeconomics
Outcomes, health economics and pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Pharmacoeconomics.ppt
Pharmacoeconomics.pptPharmacoeconomics.ppt
Pharmacoeconomics.ppt
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
PHARMACOECONOMICS.pptx
PHARMACOECONOMICS.pptxPHARMACOECONOMICS.pptx
PHARMACOECONOMICS.pptx
 
Pharmacoeconomis
PharmacoeconomisPharmacoeconomis
Pharmacoeconomis
 
Pharmacoeconomis
PharmacoeconomisPharmacoeconomis
Pharmacoeconomis
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Principles of Pharmacoeconomics and ...
Principles of Pharmacoeconomics and                                          ...Principles of Pharmacoeconomics and                                          ...
Principles of Pharmacoeconomics and ...
 
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...Is complementary and alternative medicine (CAM) cost-effective? a systematic ...
Is complementary and alternative medicine (CAM) cost-effective? a systematic ...
 
Pharmacoeconomics & pharmacoepidemioology
Pharmacoeconomics &  pharmacoepidemioologyPharmacoeconomics &  pharmacoepidemioology
Pharmacoeconomics & pharmacoepidemioology
 
pharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfpharmacoeconomic_models.pdf
pharmacoeconomic_models.pdf
 
Pharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfPharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdf
 
Accounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docxAccounting and Medicine An ExploratoryInvestigation into .docx
Accounting and Medicine An ExploratoryInvestigation into .docx
 

Más de jinender16 (9)

ISPOR
ISPORISPOR
ISPOR
 
Poster
PosterPoster
Poster
 
Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinender
 
APha Poster
APha PosterAPha Poster
APha Poster
 
Patient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To PhysiciansPatient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To Physicians
 
Singapore
SingaporeSingapore
Singapore
 
Pseudoephedrine
PseudoephedrinePseudoephedrine
Pseudoephedrine
 
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical IndustryDirect To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinender
 

Pharmacoeconomics1

  • 1.
  • 2.
  • 3.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.